Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange Post published:May 27, 2021 Post category:Press Release
Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd. Post published:May 20, 2021 Post category:Press Release
More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s First Annual “State of Mind” Survey Post published:May 18, 2021 Post category:Press Release
Field Trip Health Ltd. Announces DTC Eligibility Post published:May 6, 2021 Post category:Press Release
Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers Post published:May 4, 2021 Post category:Press Release
Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing Post published:March 17, 2021 Post category:Press Release
Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering Post published:February 26, 2021 Post category:Press Release
Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares Post published:February 25, 2021 Post category:Press Release
Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results Post published:February 16, 2021 Post category:Press Release
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results Conference Call for Wednesday, February 17, 2021 at 8:00 am ET Post published:February 10, 2021 Post category:Press Release